Ipca Laboratories Limited
IPCALAB
Κατάταξη σε μετοχές
#3411
Ipca Laboratories Limited, an integrated pharmaceutical company, manufactures... Ipca Laboratories Limited, an integrated pharmaceutical company, manufactures and markets formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India, Europe, Africa, the Americas, Asia, the Commonwealth of Independent States, and Australasia. The company offers APIs in anti-hypertensive, anti-malarial, diuretic, DMARD, anti-hypertensive, and anthelmintic therapeutic areas. It also provides generic and branded formulations in various therapeutic segments, including allergy, anti-neoplastic/cancer drugs, anti-arthritic, anti-epileptic, anti-hypertensive, cardiology, diabetes, dermatology, diabetology, emollients/protectives, fever, gastroenterology, helminthics, hepatoprotectives, immunosuppressant, infectious diseases, malaria, neurology, neuropathic pain, and NSAIDs, as well as nutraceuticals, ophthalmology, oral anti diabetes drug, orthopedics, probiotics, psychiatry, respiratory, rheumatology, and urology. The company also exports its products worldwide. Ipca Laboratories Limited was incorporated in 1949 and is based in Mumbai, India.
Τιμή μετοχής
$20.00
Κεφαλαιοποίηση
$5.08B
Αλλαγή (1 ημέρα)
-1.76%
Αλλαγή (1 έτος)
36.89%
Χώρα
IN
Εμπόριο Ipca Laboratories Limited (IPCALAB)
Κατηγορία
Healthcare
EPS για Ipca Laboratories Limited (IPCALAB)
EPS στις June 2026 TTM: $0.57
Σύμφωνα με τις τελευταίες οικονομικές αναφορές και την τιμή της μετοχής της Ipca Laboratories Limited, το τρέχον EPS της εταιρείας (TTM) είναι $0.57. Στο τέλος του 2024, η εταιρεία είχε EPS $0.26, αύξηση σε σχέση με το EPS του 2023 που ήταν $0.23.
Ιστορικό EPS της Ipca Laboratories Limited από 2005 έως 2026
EPS στο τέλος κάθε έτους
| Έτος | EPS | Αλλαγή |
|---|---|---|
| 2026 (TTM) | $0.57 | 67.59% |
| 2025 | $0.34 | 31.43% |
| 2024 | $0.26 | 14.42% |
| 2023 | $0.23 | -50.75% |
| 2022 | $0.46 | -25.34% |
| 2021 | $0.61 | 93.12% |
| 2020 | $0.32 | 25.55% |
| 2019 | $0.25 | 73.94% |
| 2018 | $0.15 | 22.62% |
| 2017 | $0.12 | 113.46% |
| 2016 | $0.06 | -65.49% |
| 2015 | $0.16 | -48.97% |
| 2014 | $0.32 | 34.08% |
| 2013 | $0.24 | 8.86% |
| 2012 | $0.22 | -7.87% |
| 2011 | $0.24 | 28.52% |
| 2010 | $0.18 | 131.65% |
| 2009 | $0.08 | -41.78% |
| 2008 | $0.14 | 16.48% |
| 2007 | $0.12 | 111.05% |
| 2006 | $0.06 | -18.58% |
| 2005 | $0.07 | 0.00% |
EPS για παρόμοιες εταιρείες ή ανταγωνιστές
| Εταιρεία | EPS | Διαφορά EPS | Χώρα |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $0.56 | -2.37% |
IN
|
